The Princess of Asturias Foundation has recognised Professor Kariko for her contribution to the development of COVID-19 vaccines.
Katalin Kariko received the award in Oviedo, Spain, on Friday 22nd October, with the Spanish royal family in attendance. She was one of seven Laureates in the ‘Technical and Scientific Research’ category for 2021 recognised for contributing to the development of some of the COVID-19 vaccines approved to date.
Hungarian biochemist Professor Katalin Kariko is Senior Vice President, BioNTech RNA Pharmaceuticals and Adjunct Associate Professor at the University of Pennsylvania. Her fields of scholarship include the therapeutic use of mRNA, mRNA-based antibody therapeutics, mRNA-based protein replacement therapy and mRNA vaccines. Professor Kariko’s research, together with immunologist Drew Weissman, led to the development of the Moderna and Pfizer-BioNTech vaccines. Together, they have received several awards for their revolutionary research, including the Lasker-DeBakey Clinical Medical Research Award. Professor Kariko was elected to the Academia Europaea in 2020.
The first paper in the series, ‘Digital Media in crisis situations: Rethinking their role and function’, is available now.
The Briefing Series has been developed to complement AE Cardiff’s webinar series. Our first briefing paper summarises key themes and ideas discussed at our ‘Digital Media in crisis situations‘ webinar, held on 1st March 2021. A panel of experts discussed the role of the digital media on our public debate, attitudes and behaviour during the COVID-19 pandemic. The event was a partnership between Academia Europaea, University of Bremen, Cardiff University, SAPEA (Science Advice for Policy by European Academies) and in support of the Welsh Government’s Wales in Germany 2021 initiative.
At this special online event held on Wales’ national day, St David’s Day, on 1st March 2021, our panellists discussed the role of the digital media on our public debate, attitudes and behaviour during the current COVID-19 pandemic. Over 100 joined the webinar from 23 countries across the world.
Academia Europaea and the Cardiff Hub were delighted to support WAAS at its recent anniversary meeting, called ‘A Planetary Moment’, held on 15th-19th February.
WAAS’s 60th anniversary meeting, held online, assembled a range of expert panels to discuss key issues such as sustainable development, the role of youth, leadership, and human security. The approach to Academia Europaea to participate in the meeting came from Professor Thomas Reuter MAE, a WAAS Board Member.
This webinar, hosted by Cardiff University on 26th January 2021, saw 6 presentations by Members of Academia Europaea, who have all recently published papers on various biomedical aspects of COVID-19. Over 100 attended the live session from 27 countries across the world.
The presentations addressed a wide range of issues, including the genetics of the disease, how the virus enters cells, a focus on the vulnerable lipid envelope of the virus, how to explain the mysterious silent hypoxemia that gives rise to uncompensated low oxygen levels in the blood, a new ion channel target in the airways and how to understand the psychiatric aspects of COVID-19. The short presentations were followed by a discussion session. The webinar was moderated by the Hub’s Director, Professor Ole Petersen.
Sir Stephen Holgate MAE leads the research group at the University of Southampton where the new treatment has been developed.
Interferon beta (IFNb) is a naturally occurring protein that orchestrates the body’s antiviral responses. Respiratory viruses, including coronavirus have developed a mechanism to suppress IFNb production by the lung, helping the virus to escape the immune response and thereby putting patients at risk of severe lung disease.
Over 240 participants attended the live session from 36 countries which was moderated by Professor Ole Petersen, Vice-President of Academia Europaea and Director of the Cardiff AE Hub, and hosted by SAPEA. The discussant was Sir Mark Walport, the incoming Chair of the Cardiff Hub Steering Group.
There is a high level of trust in scientists and a low level of trust in politicians. How is working together likely to impact on levels of trust in scientists and politicians and the relationship between scientists and politicians?